Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 8, 2015, Pages 714-723

  Zhu, X ^a   Sun, X ^a   Wang, M ^a   Zhang, C ^a   Cao, Y ^a   Mo, G ^a   Liang, J ^a   Zhu, S ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Beta glucan; Dietary fiber; Hypercholesterolemic; Meta analysis; Serum lipids

Indexed keywords

BETA GLUCAN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN;

ARTICLE; BODY MASS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SENSITIVITY ANALYSIS; ADMINISTRATION AND DOSAGE; AVENA; BLOOD; CHEMISTRY; DIET THERAPY; DIETARY FIBER; DRUG EFFECTS; FEMALE; HORDEUM; MALE; TREATMENT OUTCOME;

AVENA; HORDEUM;

AVENA; BETA-GLUCANS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, LDL; DIETARY FIBER; FEMALE; HORDEUM; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, HDL; MALE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84937526110     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.04.008     Document Type: Article

References (34)

1. World Health Organization Statistics Cardiovascular diseases 2013, Available from:, [accessed 27.02.14]. http://www.who.int/mediacentre/factsheets/fs317/en/index.html.
2. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study. Lancet 1997, 349:1498-1504.
3. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
4. Ballantyne C., Arroll B., Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J 2005, 26:2224-2231.
5. Chen Z.Y., Jiao R., Ma K.Y. Cholesterol-lowering nutraceuticals and functional foods. J Agric Food Chem 2008, 56:8761-8773.
6. Threapleton D.E., Greenwood D.C., Evans C.E., Cleghorn C.L., Nykjaer C., Woodhead C., et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ (Clin Res Ed) 2013, 347:f6879.
7. Othman R.A., Moghadasian M.H., Jones P.J. Cholesterol-lowering effects of oat beta-glucan. Nutr Rev 2011, 69:299-309.
8. Higgins J.P., Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011) 2011, Available from:, The Cochrane Collaboration. http://handbook.cochrane.org/.
9. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 1997, 315:629-634.
10. McIntosh G.H., Whyte J., McArthur R., Nestel P.J. Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. Am J Clin Nutr 1991, 53:1205-1209.
11. Uusitupa M.I., Ruuskanen E., Makinen E., Laitinen J., Toskala E., Kervinen K., et al. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 1992, 11:651-659.
12. Davidson M.H., Dugan L.D., Burns J.H., Bova J., Story K., Drennan K.B. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. J Am Med Assoc 1991, 265:1833-1839.
13. Uusitupa M.I., Miettinen T.A., Sarkkinen E.S., Ruuskanen E., Kervinen K., Kesaniemi Y.A. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. Eur J Clin Nutr 1997, 51:607-611.
14. Onning G., Wallmark A., Persson M., Akesson B., Elmstahl S., Oste R. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 1999, 43:301-309.
15. Lovegrove J.A., Clohessy A., Milon H., Williams C.M. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 2000, 72:49-55.
16. Keogh G.F., Cooper G.J., Mulvey T.B., McArdle B.H., Coles G.D., Monro J.A., et al. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 2003, 78:711-718.
17. Kerckhoffs D.A., Hornstra G., Mensink R.P. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 2003, 78:221-227.
18. Maki K.C., Shinnick F., Seeley M.A., Veith P.E., Quinn L.C., Hallissey P.J., et al. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr 2003, 133:808-813.
19. Biorklund M., van Rees A., Mensink R.P., Onning G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 2005, 59:1272-1281.
20. Karmally W., Montez M.G., Palmas W., Martinez W., Branstetter A., Ramakrishnan R., et al. Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans. J Am Diet Assoc 2005, 105:967-970.
21. Keenan J.M., Goulson M., Shamliyan T., Knutson N., Kolberg L., Curry L. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women. Br J Nutr 2007, 97:1162-1168.
22. Queenan K.M., Stewart M.L., Smith K.N., Thomas W., Fulcher R.G., Slavin J.L. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007, 6:6.
23. Shimizu C., Kihara M., Aoe S., Araki S., Ito K., Hayashi K., et al. Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men-a randomized, double-blinded, placebo-controlled trial. Plant Foods Hum Nutr (Dordrecht, Netherlands) 2008, 63:21-25.
24. Biorklund M., Holm J., Onning G. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann Nutr Metab 2008, 52:83-90.
25. Rondanelli M., Opizzi A., Monteferrario F., Klersy C., Cazzola R., Cestaro B. Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men. Eur J Clin Nutr 2011, 65:864-871.
26. Charlton K.E., Tapsell L.C., Batterham M.J., O'Shea J., Thorne R., Beck E., et al. Effect of 6 weeks' consumption of beta-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br J Nutr 2012, 107:1037-1047.
27. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 2001, 285:2486-2497.
28. Brown L., Rosner B., Willett W.W., Sacks F.M. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999, 69:30-42.
29. Tiwari U., Cummins E. Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition (Burbank, Los Angeles County, Calif) 2011, 27:1008-1016.
30. Whitehead A., Beck E.J., Tosh S., Wolever T.M. Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2014, 100:1413-1421.
31. Talati R., Baker W.L., Pabilonia M.S., White C.M., Coleman C.I. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 2009, 7:157-163.
32. Bae I.Y., Kim S.M., Lee S., Lee H.G. Effect of enzymatic hydrolysis on cholesterol-lowering activity of oat beta-glucan. New Biotechnol 2010, 27:85-88.
33. Andersson K.E., Svedberg K.A., Lindholm M.W., Oste R., Hellstrand P. Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice. Atherosclerosis 2010, 212:93-99.
34. Drozdowski L.A., Reimer R.A., Temelli F., Bell R.C., Vasanthan T., Thomson A.B. Beta-glucan extracts inhibit the invitro intestinal uptake of long-chain fatty acids and cholesterol and down-regulate genes involved in lipogenesis and lipid transport in rats. J Nutr Biochem 2010, 21:695-701.